Reversible_thyroid_dysfunction_during_treatment_with_GM-CSF._To_investigate_whether_autoimmunity_against_thyroid_antigens_is_induced_or_exacerbated_by_granulocyte-macrophage_colony-stimulating_factor,_thyroid_function_and_thyroid_autoantibodies_were_studied_in_14_patients_with_advanced_breast_cancer_and_11_with_soft-tissue_sarcoma_who_received_several_cycles_of_doxorubicin_and_cyclophosphamide_plus_GM-CSF_250_micrograms/m2_intravenously_daily_for_10_days_in_every_21_day_cycle._All_patients_had_normal_thyroid_function_before_treatment._In_2_patients_with_pre-existing_thyroid_antibodies,_thyroid_dysfunction_developed_but_disappeared_after_cessation_of_GM-CSF._No_other_autoimmune_abnormalities_appeared._Stimulation_of_antigen-presenting_cells_by_GM-CSF_may_bring_about_this_phenomenon.